HUQ, Shihan Mahmud Redwanul et al.
 Survival Benefit of High Dose Versus Usual Dose of Baricitinib in Hospitalized Patients with COVID-19: A Systematic Review.
<strong>Medical Research Archives</strong>, [S.l.], v. 10, n. 9, sep. 2022.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/3076" target="_new">https://esmed.org/MRA/mra/article/view/3076</a>&gt;. Date accessed: 25 nov. 2024.
doi: <a href="https://doi.org/10.18103/mra.v10i9.3076">https://doi.org/10.18103/mra.v10i9.3076</a>.